Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 175Thoracic 36Gastrointestinal 33Gynecologic 24Breast 22Head & Neck 20Dermatologic 20Sarcoma 12Other solid neoplasm 5Lymphoid 5CNS 5Plasma cell 2Other hematologic neoplasm 2Myeloid 1Endocrine 1Classical hematology 1

Conditions

Anemia 43Anemia, Refractory, with Excess of Blasts 40Leukemia, Myeloid, Acute 38Myelodysplastic Syndromes 36Leukemia 34Neoplasms 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Multiple Myeloma 25Thrombocytopenia 23Leukemia, Lymphocytic, Chronic, B-Cell 21Primary Myelofibrosis 20Lymphoma 20Lymphoma, Non-Hodgkin 19Leukemia, Myelomonocytic, Chronic 18Venous Thromboembolism 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Hodgkin Disease 16Myeloproliferative Disorders 15Lymphoma, Mantle-Cell 14Anemia, Aplastic 14Anemia, Refractory 13Lymphoma, Follicular 12Hematologic Neoplasms 12Lymphoma, Large B-Cell, Diffuse 11Congenital Abnormalities 10Neoplasms, Plasma Cell 9Myelodysplastic-Myeloproliferative Diseases 9Lymphoma, Large-Cell, Immunoblastic 9Leukemia, Myeloid, Chronic-Phase 9Burkitt Lymphoma 9

Interventions

ACE-011 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Urinary Bladder Neoplasms × Classical hematology × Clear all
NCT01284348 2024-08-29

To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer

Merck Sharp & Dohme LLC

Phase 2 Terminated
26 enrolled 18 charts
Classical hematologyGenitourinaryGynecologicHead & NeckThoracic

Anemia, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡